Home > Ramesh Daggubati, C3 2019 – Antiplatelet Therapy
Interventional Cardiology

Ramesh Daggubati, C3 2019 – Antiplatelet Therapy

Published Online: July 8th 2019

We spoke to Dr Ramesh Daggubati (New York University Winthrop Hospital, Mineola, NY, USA) about the latest developments in mitral valve technology at C3 2019.

Speaker’s Disclosures: Ramesh Daggubati is a consultant for Abiomed, Meril and Medtronic.

Questions:
1. What is the current status of antiplatelet therapy and dual versus triple antiplatelet therapy? (0:04)
2. Where does the future lie in antiplatelet therapy? (0:49)
3. What are the latest technological developments in mitral valve technology? (1:41)

touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.

Share this Video
Related Videos In Interventional Cardiology
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar